Procter & Gamble (PG) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

PG Stock Forecast


Procter & Gamble stock forecast is as follows: an average price target of $172.40 (represents a 3.71% upside from PG’s last price of $166.23) and a rating consensus of 'Buy', based on 21 wall street analysts offering a 1-year stock forecast.

PG Price Target


The average price target for Procter & Gamble (PG) is $172.40 based on 1-year price targets from 21 Wall Street analysts in the past 3 months, with a price target range of $192.00 to $159.00. This represents a potential 3.71% upside from PG's last price of $166.23.

PG Analyst Ratings


Buy

According to 21 Wall Street analysts, Procter & Gamble's rating consensus is 'Buy'. The analyst rating breakdown for PG stock is 0 'Strong Buy' (0.00%), 13 'Buy' (61.90%), 8 'Hold' (38.10%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Procter & Gamble Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 23, 2025Lauren LiebermanBarclays$159.00$164.74-3.48%-4.35%
Dec 05, 2024Kaumil GajrawalaJefferies$174.00$175.69-0.96%4.67%
Nov 22, 2024Mark AstrachanStifel Nicolaus$167.00$176.28-5.26%0.46%
Oct 21, 2024Bill ChappellTruist Financial$180.00$169.646.11%8.28%
Oct 21, 2024Nik ModiRBC Capital$164.00$169.00-2.96%-1.34%
Oct 21, 2024Linda Bolton WeiserD.A. Davidson$160.00$169.01-5.33%-3.75%
Oct 21, 2024Olivia TongRaymond James$190.00$171.2810.93%14.30%
Oct 09, 2024Linda Bolton WeiserD.A. Davidson$159.00$169.27-6.07%-4.35%
Oct 04, 2024Bonnie HerzogGoldman Sachs$164.00$168.88-2.89%-1.34%
Sep 30, 2024Lauren LiebermanBarclays$163.00$173.55-6.08%-1.94%
Sep 23, 2024Korinne WolfmeyerPiper Sandler$174.00$173.770.13%4.67%
Sep 16, 2024Kevin GrundyBNP Paribas$192.00$177.028.46%15.50%
Jul 24, 2024Kaumil GajrawalaJefferies$175.00$165.935.47%5.28%
Jul 22, 2024Mark AstrachanStifel Nicolaus$161.00$167.96-4.14%-3.15%
Jul 18, 2024Robert OttensteinEvercore ISI$183.00$169.448.00%10.09%
Jul 17, 2024Steve PowersDeutsche Bank$176.00$168.534.43%5.88%
Jun 24, 2024Kevin GrundyBNP Paribas$187.00$168.2611.14%12.49%
Apr 25, 2024Chris GrajaArgus Research$185.00$162.8813.58%11.29%
Apr 23, 2024Lauren LiebermanBarclays$170.00$160.545.89%2.27%
Nov 24, 2023Alexia HowardBernstein$40.00$151.38-73.58%-75.94%
Oct 18, 2023Dara MohsenianMorgan Stanley$174.00$146.2618.97%4.67%
Jan 13, 2023Olivia TongRaymond James$170.00$150.2513.14%2.27%
Jan 13, 2023J.P. Morgan$150.00$149.870.09%-9.76%
Jan 03, 2023Wells Fargo$168.00$150.6211.54%1.06%
Dec 06, 2022Deutsche Bank$162.00$148.479.11%-2.54%
Nov 16, 2022Wells Fargo$155.00$140.4910.33%-6.76%
Nov 15, 2022Credit Suisse$130.00$141.66-8.23%-21.80%
Oct 12, 2022Olivia TongRaymond James$155.00$124.4324.57%-6.76%
Oct 09, 2022Jason EnglishGoldman Sachs$143.00$124.2715.07%-13.97%
Oct 03, 2022Wells Fargo$150.00$126.2518.81%-9.76%
Aug 18, 2022Lauren LiebermanBarclays$154.00$149.812.80%-7.36%
Aug 01, 2022Truist Financial$160.00$142.6012.20%-3.75%
Jul 21, 2022J.P. Morgan$156.00$139.7711.61%-6.15%
Jun 21, 2022Deutsche Bank$157.00$135.8115.60%-5.55%
Jun 19, 2022Steve PowersDeutsche Bank$171.00$132.3629.19%2.87%
Jun 06, 2022Chris CareyWells Fargo$170.00$145.4616.87%2.27%
May 23, 2022Barclays$157.00$141.7910.73%-5.55%
Apr 26, 2022Kaumil GajrawalaCredit Suisse$150.00$161.74-7.26%-9.76%
Apr 22, 2022Barclays$176.00$161.399.05%5.88%
Apr 21, 2022Deutsche Bank$177.00$164.547.57%6.48%
Apr 21, 2022Raymond James$180.00$163.659.99%8.28%
Apr 19, 2022Peter GromUBS$160.00$158.520.93%-3.75%
Apr 11, 2022Olivia TongRaymond James$175.00$159.499.72%5.28%
Apr 01, 2022Jason EnglishGoldman Sachs$173.00$155.0911.55%4.07%
Mar 23, 2022Bill ChappellTruist Financial$175.00$150.8216.03%5.28%
Jan 20, 2022Peter GromUBS$163.00$162.000.62%-1.94%
Jan 20, 2022Dara MohsenianMorgan Stanley$177.00$162.009.26%6.48%
Jan 19, 2022Kevin GrundyJefferies$187.00$161.1316.06%12.49%
Jan 19, 2022Mark AstrachanStifel Nicolaus$148.00$161.13-8.15%-10.97%
Jan 05, 2022Christopher CareyWells Fargo$180.00$163.3310.21%8.28%
Oct 05, 2021Bryan SpillaneBank of America Securities$160.00$137.7316.17%-3.75%
Aug 04, 2021Lars LusebrinkIndependent Research$154.00$140.799.38%-7.36%
Aug 02, 2021Kaumil GajrawalaCredit Suisse$145.00$140.253.39%-12.77%
Apr 21, 2021Michael PohnDZ BANK AG$119.00$133.58-10.91%-28.41%

The latest Procter & Gamble stock forecast, released on Jan 23, 2025 by Lauren Lieberman from Barclays, set a price target of $159.00, which represents a -3.48% decrease from the stock price at the time of the forecast ($164.74), and a -4.35% decrease from PG last price ($166.23).

Procter & Gamble Price Target by Period


1M3M12M
# Anlaysts1319
Avg Price Target$159.00$166.67$172.79
Last Closing Price$166.23$166.23$166.23
Upside/Downside-4.35%0.26%3.95%

In the current month, the average price target of Procter & Gamble stock is $159.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a -4.35% decrease as opposed to Procter & Gamble's last price of $166.23. This month's average price target is down -4.60% compared to last quarter, and down -7.98% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Jan 23, 2025RBC CapitalSector PerformSector PerformDowngrade
Jan 23, 2025BarclaysEqual-WeightEqual-WeightHold
Jan 23, 2025Wells FargoOverweightOverweightHold
Dec 05, 2024JefferiesHoldHoldHold
Oct 21, 2024Cowen & Co.BuyBuyHold
Oct 21, 2024Morgan StanleyOverweightOverweightHold
Oct 21, 2024Piper SandlerUnderperformUnderperformHold
Oct 21, 2024Evercore ISIOutperformOutperformHold
Oct 21, 2024Raymond JamesOutperformOutperformHold
Oct 15, 2024RBC CapitalSector PerformSector PerformHold
Oct 09, 2024D.A. DavidsonNeutralInitialise
Oct 04, 2024Goldman SachsNeutralNeutralHold
Sep 30, 2024BarclaysOverweightEqual-WeightDowngrade
Sep 23, 2024Piper SandlerNeutralInitialise
Sep 16, 2024Exane BNP ParibasOutperformOutperformHold
Sep 16, 2024BNP ParibasOutperformOutperformHold
Jul 31, 2024RBC CapitalSector PerformSector PerformHold
Jul 24, 2024JefferiesHoldDowngrade
Jul 22, 2024Cowen & Co.BuyInitialise
Jul 19, 2024BarclaysOverweightOverweightHold
Jul 18, 2024Evercore ISIOutperformOutperformHold
Jul 17, 2024Deutsche BankBuyBuyHold
Jul 10, 2024CitigroupBuyBuyHold
Jun 24, 2024Exane BNP ParibasOutperformInitialise
Apr 12, 2024BarclaysOverweightOverweightHold
Apr 03, 2024Deutsche BankBuyBuyHold
Jan 24, 2024RBC CapitalSector PerformSector PerformHold
Nov 24, 2023BernsteinMarket PerformOutperformUpgrade
Nov 24, 2023Morgan StanleyOverweightOverweightHold
Oct 19, 2023Raymond JamesOutperformOutperformHold
Oct 18, 2023Morgan StanleyOverweightOverweightHold
Oct 18, 2023BarclaysOverweightOverweightHold
Oct 18, 2023BernsteinMarket PerformMarket PerformHold
Jul 31, 2023Deutsche BankBuyBuyHold
Apr 24, 2023Raymond JamesOutperformOutperformHold
Apr 24, 2023Morgan StanleyOverweightOverweightHold
Mar 21, 2023J.P. MorganOverweightUpgrade
Mar 01, 2023RBC CapitalSector PerformDowngrade
Mar 01, 2023Keefe, Bruyette & WoodsMarket PerformDowngrade
Mar 01, 2023BenchmarkBuyUpgrade
Mar 01, 2023Roth CapitalNeutralUpgrade
Mar 01, 2023UBSBuyUpgrade
Jan 13, 2023Raymond JamesOutperformOutperformHold
Jan 03, 2023Wells FargoOverweightOverweightHold
Dec 06, 2022Deutsche BankBuyBuyHold
Nov 16, 2022Wells FargoOverweightOverweightHold
Nov 15, 2022Credit SuisseNeutralNeutralHold
Oct 12, 2022Raymond JamesOutperformOutperformHold
Oct 09, 2022Goldman SachsBuyNeutralDowngrade
Oct 03, 2022Wells FargoOverweightOverweightHold
Aug 02, 2022BarclaysOverweightOverweightHold
Jul 25, 2022Raymond JamesOutperformOutperformHold
Jun 01, 2022Deutsche BankBuyBuyHold
Jun 01, 2022Wells FargoOverweightOverweightHold
Apr 26, 2022Credit SuisseNeutralNeutralHold
Apr 11, 2022Raymond JamesOutperformInitialise
Apr 01, 2022Goldman SachsBuyBuyHold
Jan 23, 2022Morgan StanleyOverweightOverweightHold

Procter & Gamble's last stock rating was published by RBC Capital on Jan 23, 2025. The company gave PG a "Sector Perform" rating, the same as its previous rate.

Procter & Gamble Financial Forecast


Procter & Gamble Revenue Forecast

Jun 28Mar 28Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
Revenue------------------$21.44B$21.87B$20.55B$20.07B$20.77B$20.61B$19.52B$19.38B$20.95B$20.34B$18.95B$18.11B
Avg Forecast$23.55B$23.04B$24.14B$23.80B$22.68B$22.02B$23.35B$23.07B$21.91B$21.30B$22.53B$22.30B$21.13B$20.54B$21.58B$21.99B$20.72B$20.43B$21.48B$21.58B$20.01B$19.28B$20.75B$20.37B$19.40B$18.71B$20.33B$19.83B$18.37B$17.96B
High Forecast$23.90B$23.39B$24.51B$24.17B$23.03B$22.35B$23.70B$23.42B$22.25B$21.63B$22.87B$22.64B$21.45B$20.80B$21.78B$22.04B$20.74B$20.43B$21.74B$21.91B$20.31B$19.57B$21.10B$20.37B$19.40B$18.71B$20.33B$19.83B$18.37B$17.96B
Low Forecast$23.09B$22.60B$23.68B$23.35B$22.25B$21.59B$22.90B$22.62B$21.49B$20.89B$22.10B$21.87B$20.72B$20.08B$21.30B$21.93B$20.71B$20.43B$21.09B$21.17B$19.63B$18.91B$20.38B$20.37B$19.40B$18.71B$20.33B$19.83B$18.37B$17.96B
# Analysts55666666612111091313855115510544755107
Surprise %------------------1.00%1.01%1.03%1.04%1.00%1.01%1.01%1.04%1.03%1.03%1.03%1.01%

Procter & Gamble's average Quarter revenue forecast for Mar 24 based on 5 analysts is $20.43B, with a low forecast of $20.43B, and a high forecast of $20.43B. PG's average Quarter revenue forecast represents a -4.69% decrease compared to the company's last Quarter revenue of $21.44B (Dec 23).

Procter & Gamble EBITDA Forecast

Jun 28Mar 28Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
# Analysts55666666612111091313855115510544755107
EBITDA------------------$4.43B$5.77B$5.18B$5.20B$5.01B$5.78B$4.49B$4.18B$6.01B$5.84B$4.39B$4.69B
Avg Forecast$6.34B$6.20B$6.50B$6.41B$6.10B$5.93B$6.28B$6.21B$5.90B$5.73B$6.06B$6.00B$5.69B$5.53B$5.81B$5.92B$5.58B$5.70B$5.78B$5.81B$5.39B$5.18B$6.57B$5.51B$5.25B$4.71B$5.50B$5.36B$4.97B$4.41B
High Forecast$6.43B$6.30B$6.60B$6.50B$6.20B$6.02B$6.38B$6.30B$5.99B$5.82B$6.16B$6.09B$5.77B$5.60B$5.86B$5.93B$5.58B$6.84B$5.85B$5.90B$5.47B$6.21B$7.89B$5.51B$5.25B$5.65B$5.50B$5.36B$4.97B$5.29B
Low Forecast$6.22B$6.08B$6.37B$6.28B$5.99B$5.81B$6.16B$6.09B$5.79B$5.62B$5.95B$5.89B$5.58B$5.41B$5.73B$5.90B$5.57B$4.56B$5.68B$5.70B$5.28B$4.14B$5.26B$5.51B$5.25B$3.77B$5.50B$5.36B$4.97B$3.53B
Surprise %------------------0.77%0.99%0.96%1.00%0.76%1.05%0.86%0.89%1.09%1.09%0.88%1.06%

5 analysts predict PG's average Quarter EBITDA for Mar 24 to be $5.70B, with a high of $6.84B and a low of $4.56B. This is 28.49% upper than Procter & Gamble's previous annual EBITDA (Dec 23) of $4.43B.

Procter & Gamble Net Income Forecast

Jun 28Mar 28Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
# Analysts55666666612111091313855115510544755107
Net Income------------------$16.20M$4.52B$3.38B$3.40B$3.93B$3.94B$3.05B$3.35B$4.24B$4.11B$2.91B$3.27B
Avg Forecast$4.64B$4.80B$5.61B$5.62B$4.37B$4.47B$5.29B$5.21B$4.05B$4.19B$4.96B$4.92B$3.77B$3.89B$4.57B$4.67B$3.38B$3.93B$4.17B$4.23B$3.25B$3.58B$4.62B$3.84B$3.02B$3.25B$4.08B$3.93B$2.68B$3.08B
High Forecast$4.73B$4.89B$5.72B$5.73B$4.46B$4.55B$5.40B$5.31B$4.13B$4.27B$5.06B$5.02B$3.84B$4.01B$4.67B$4.68B$3.42B$4.72B$4.22B$4.31B$3.32B$4.29B$5.54B$3.84B$3.11B$3.90B$4.08B$3.93B$2.77B$3.69B
Low Forecast$4.52B$4.68B$5.47B$5.48B$4.27B$4.35B$5.16B$5.08B$3.95B$4.08B$4.84B$4.80B$3.68B$3.84B$4.47B$4.66B$3.34B$3.15B$4.07B$4.12B$3.17B$2.86B$3.69B$3.84B$2.94B$2.60B$4.08B$3.93B$2.59B$2.46B
Surprise %------------------0.00%1.07%1.04%0.95%0.85%1.03%1.01%1.03%1.04%1.05%1.08%1.06%

Procter & Gamble's average Quarter net income forecast for Mar 24 is $3.93B, with a range of $3.15B to $4.72B. PG's average Quarter net income forecast represents a 24181.93% increase compared to the company's last Quarter net income of $16.20M (Dec 23).

Procter & Gamble SG&A Forecast

Jun 28Mar 28Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
# Analysts55666666612111091313855115510544755107
SG&A------------------$5.52B$5.60B$5.78B$5.42B$5.09B$4.83B$5.12B$5.03B$5.12B$4.95B$5.62B$5.40B
Avg Forecast$6.33B$6.20B$6.49B$6.40B$6.10B$5.92B$6.28B$6.20B$5.89B$5.73B$6.06B$6.00B$5.68B$5.52B$5.80B$5.91B$5.57B$5.90B$5.78B$5.80B$5.38B$5.36B$5.60B$5.38B$5.12B$4.88B$5.37B$5.24B$4.85B$5.08B
High Forecast$6.43B$6.29B$6.59B$6.50B$6.19B$6.01B$6.38B$6.30B$5.98B$5.82B$6.15B$6.09B$5.77B$5.59B$5.86B$5.93B$5.58B$7.08B$5.85B$5.89B$5.46B$6.43B$6.72B$5.38B$5.12B$5.85B$5.37B$5.24B$4.85B$6.10B
Low Forecast$6.21B$6.08B$6.37B$6.28B$5.98B$5.81B$6.16B$6.09B$5.78B$5.62B$5.94B$5.88B$5.57B$5.40B$5.73B$5.90B$5.57B$4.72B$5.67B$5.69B$5.28B$4.29B$4.48B$5.38B$5.12B$3.90B$5.37B$5.24B$4.85B$4.07B
Surprise %------------------0.96%0.97%1.07%1.01%0.91%0.90%1.00%1.03%0.95%0.95%1.16%1.06%

Procter & Gamble's average Quarter SG&A projection for Mar 24 is $5.90B, based on 5 Wall Street analysts, with a range of $4.72B to $7.08B. The forecast indicates a 6.82% rise compared to PG last annual SG&A of $5.52B (Dec 23).

Procter & Gamble EPS Forecast

Jun 28Mar 28Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
# Analysts55666666612111091313855115510544755107
EPS------------------$0.01$1.89$1.40$1.41$1.63$1.62$1.24$1.37$1.76$1.66$1.16$1.30
Avg Forecast$1.89$1.95$2.28$2.29$1.78$1.82$2.15$2.12$1.65$1.70$2.02$2.00$1.53$1.58$1.86$1.90$1.37$1.42$1.70$1.72$1.32$1.32$1.59$1.55$1.22$1.29$1.65$1.59$1.08$1.19
High Forecast$1.92$1.99$2.33$2.33$1.81$1.85$2.19$2.16$1.68$1.74$2.06$2.04$1.56$1.63$1.90$1.90$1.39$1.42$1.72$1.75$1.35$1.38$1.62$1.55$1.26$1.36$1.65$1.59$1.12$1.19
Low Forecast$1.84$1.90$2.22$2.23$1.74$1.77$2.10$2.07$1.61$1.66$1.97$1.95$1.50$1.56$1.82$1.89$1.36$1.42$1.66$1.68$1.29$1.27$1.55$1.55$1.19$1.22$1.65$1.59$1.05$1.19
Surprise %------------------0.00%1.10%1.06%1.07%1.03%1.04%1.01%1.06%1.07%1.04%1.07%1.09%

According to 5 Wall Street analysts, Procter & Gamble's projected average Quarter EPS for Mar 24 is $1.42, with a low estimate of $1.42 and a high estimate of $1.42. This represents a 21368.03% increase compared to PG previous annual EPS of $0.01 (Dec 23).

Procter & Gamble Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
COTYCoty$7.26$12.5072.18%Buy
ELFe.l.f. Beauty$105.96$154.2045.53%Buy
ELEstée Lauder Companies$82.28$110.6034.42%Hold
ULUnilever$57.27$72.0025.72%Buy
CLColgate-Palmolive$89.57$110.5023.37%Buy
KMBKimberly-Clark$129.67$151.0016.45%Hold
KVUEKenvue$21.31$24.7516.14%Buy
PGProcter & Gamble$166.23$172.403.71%Buy
CLXClorox$157.81$159.501.07%Hold
CHDChurch & Dwight$106.77$106.20-0.53%Hold

PG Forecast FAQ


Is Procter & Gamble a good buy?

Yes, according to 21 Wall Street analysts, Procter & Gamble (PG) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 13 'Buy' recommendations, accounting for 61.90% of PG's total ratings.

What is PG's price target?

Procter & Gamble (PG) average price target is $172.4 with a range of $159 to $192, implying a 3.71% from its last price of $166.23. The data is based on 21 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Procter & Gamble stock go up soon?

According to Wall Street analysts' prediction for PG stock, the company can go up by 3.71% (from the last price of $166.23 to the average price target of $172.4), up by 15.50% based on the highest stock price target, and down by -4.35% based on the lowest stock price target.

Can Procter & Gamble stock reach $200?

PG's average twelve months analyst stock price target of $172.4 does not support the claim that Procter & Gamble can reach $200 in the near future.

What is Procter & Gamble's current price target trend?

1 Wall Street analyst forecast a $159 price target for Procter & Gamble (PG) this month, down -4.35% from its last price of $166.23. Compared to the last 3 and 12 months, the average price target increased by 0.26% and increased by 3.95%, respectively.

What are Procter & Gamble's analysts' financial forecasts?

Procter & Gamble's analysts financial forecasts for the fiscal year (Jun 2027) are as follows: average revenue is $91.11B (high $92.49B, low $89.36B), average EBITDA is $24.52B (high $24.9B, low $24.05B), average net income is $19.34B (high $19.72B, low $18.86B), average SG&A $24.51B (high $24.88B, low $24.04B), and average EPS is $7.87 (high $8.02, low $7.67). PG's analysts financial forecasts for the fiscal year (Jun 2028) are as follows: average revenue is $94.54B (high $95.97B, low $92.72B), average EBITDA is $25.45B (high $25.83B, low $24.96B), average net income is $20.66B (high $21.07B, low $20.15B), average SG&A $25.43B (high $25.81B, low $24.94B), and average EPS is $8.41 (high $8.57, low $8.2).

Did the PG's actual financial results beat the analysts' financial forecasts?

Based on Procter & Gamble's last annual report (Jun 2023), the company's revenue was $82.01B, beating the average analysts forecast of $80.4B by 1.99%. Apple's EBITDA was $21.82B, missing the average prediction of $22.64B by -3.62%. The company's net income was $14.65B, missing the average estimation of $15.28B by -4.12%. Apple's SG&A was $21.11B, missing the average forecast of $21.72B by -2.81%. Lastly, the company's EPS was $6.07, beating the average prediction of $5.78 by 4.93%. In terms of the last quarterly report (Dec 2023), Procter & Gamble's revenue was $21.44B, missing the average analysts' forecast of $21.48B by -0.16%. The company's EBITDA was $4.43B, missing the average prediction of $5.78B by -23.32%. Procter & Gamble's net income was $16.2M, missing the average estimation of $4.17B by -99.61%. The company's SG&A was $5.52B, missing the average forecast of $5.78B by -4.41%. Lastly, the company's EPS was $0.0066, missing the average prediction of $1.7 by -99.61%